You are here: Industry Insights > Roche

News List

MHRA accepts Roche's Tecentriq into Early Access to Medicines scheme pharmafile
January 26, 2017
The decision means that patients suffering from the illness could have access to the drug while it awaits decision from the UK and Europe’s regulatory bodies.
US FDA accepts Roche’s supplemental biologics licence application pharmaceutical-technology
January 13, 2017
The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics Licence Application (sBLA) and granted priority review for Tecentriq (atezolizumab) to treat people with locally advanced or metastatic urothelial carcinoma (mUC).
US FDA accepts Roche’s supplemental biologics licence application pharmaceutical-technology
January 11, 2017
The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics Licence Application (sBLA) and granted priority review for Tecentriq (atezolizumab) to treat people with locally advanced or metastatic urothelial carcinoma (mUC).
Interview: Roche discusses the importance of sustainability in pharma manufacturing pharmafile
January 09, 2017
Peter Schurrenberger, Chief Safety, Health and Environment Officer at Roche, discusses their recent recognition as a leader for corporate action on climate change by the CDP.
Roche Gets FDA Clearance for 18-Minute Anti-Müllerian Hormone Test to Assess Ovarian Reserve americanpharmaceuticalreview
January 09, 2017
Roche has received clearance from U.S. Food and Drug Administration (FDA) via Direct de novo decision on their Anti-Müllerian (AMH) assay, making it the first approved fully automated AMH test available in the US to doctors looking to help women who are

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page